Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889414) titled 'B5 Serum 4-week Clinical Study' on Oct. 16.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: ChinaNorm

Condition: Assessment of Soothing, Moisturizing and Skin Barrier Repair Efficacy of Facial Skincare Products in Healthy Women

Intervention: Other: Topical facial serum (Serum 2.0)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 23, 2026

Target Sample Size: 124

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT0...